Process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need.
View this resource Bookmark this resource
FDA Expedited Program for serious conditions – Fast Track Designation
Published by IRDiRC
Regulatory AffairsEarly Access SupportRare DiseaseRegulatory AdviceFast Track DesignationExpedited Programme